Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1.
There are at least two phases of beta-cell death during the development of autoimmune diabetes: an initiation event that results in the release of beta-cell-specific antigens, and a second, antigen-driven event in which beta-cell death is mediated by the actions of T lymphocytes. In this report, the...
Main Authors: | Sarah A Steer, Anna L Scarim, Kari T Chambers, John A Corbett |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2006-02-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC1316065?pdf=render |
Similar Items
-
Interleukin-1 Stimulates beta-Cell Necrosis and Release of the Immunological Adjuvant HMGB1.
Published: (2005-12-01) -
HMGB1 is an endogenous immune adjuvant released by necrotic cells.
by: Rovere-Querini, P, et al.
Published: (2004) -
Interleukin-1 beta and interleukin-6 stimulate neurohypophysial hormone release in vitro.
by: Yasin, SA, et al.
Published: (1994) -
Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect.
by: Honegger, J, et al.
Published: (1991) -
Regulation of HMGB1 Release in Health and Diseases
by: Haichao Wang
Published: (2022-12-01)